BridgeBio Pharma (BBIO) Gross Profit Growth (1y) (2021 - 2026)
BridgeBio Pharma (BBIO) Gross Profit Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn | 41.37% |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn | 7.76% |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 16.94% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | 68.41% |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 83.14% |
| 10 | BridgeBio Pharma | 16.44 Bn | 15.50 Bn | 184.58 Mn | 61.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.92% |
| Dec 31, 2025 | 3,746.00% |
| Sep 30, 2025 | 5,248.50% |
| Jun 30, 2025 | 6,709.68% |
| Mar 31, 2025 | -45.85% |
| Dec 31, 2024 | 231.12% |
| Sep 30, 2024 | -38.91% |
| Jun 30, 2024 | 50.67% |
| Mar 31, 2024 | 17,816.77% |
| Dec 31, 2023 | -6.21% |
| Sep 30, 2023 | 971.07% |
| Jun 30, 2023 | -98.57% |
| Mar 31, 2023 | 239.60% |
| Dec 31, 2022 | -85.52% |
| Sep 30, 2022 | -145.06% |
| Jun 30, 2022 | 35.48% |
| Dec 31, 2021 | 6,825.41% |
| Sep 30, 2021 | -89.05% |